CDXS vs GILD: Which Stock is Better?

Side-by-side comparison of Codexis Inc and Gilead Sciences Inc in 2026

Comparison Updated:

CDXS

Codexis Inc

$2.59

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricCDXSGILDWinner
Market Cap$230.81M$171.97BGILD
P/E RatioN/A20.44GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth0.8%0.0%CDXS
Gross Margin12.4%78.8%GILD

Analyze CDXS

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CDXS or GILD a better investment?

Comparing CDXS and GILD: Codexis Inc has a market cap of $230.81M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CDXS and GILD?

CDXS (Codexis Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CDXS or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CDXS or GILD?

CDXS has higher revenue growth at 0.8% vs 0.0% for GILD.

Which company is more profitable: CDXS or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 12.4% for CDXS.

Which is the larger company: CDXS or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $230.81M for CDXS.

Should I buy CDXS or GILD in 2026?

Both CDXS and GILD have investment merit. CDXS trades at $2.59 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CDXS and GILD stock?

Key differences: Market Cap ($230.81M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.8% vs 0.0%), Gross Margin (12.4% vs 78.8%).

Popular Stock Comparisons